Teva Pharmaceutical is a leader in generic drugs, but these struggling makers of branded drugs may be a better choice.

Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 billion. The acquisition – which was confirmed to be in the final stages of ...

Private jets owned by six of the largest U.S. drugmakers have touched down in Washington-area airports 127 times this year, while millions of Americans are struggling to afford prescription drugs, ...

Leg-spinner Yuzvendra Chahal's maiden six-wicket for India as the hosts beat England by 75 runs in the third and final Twenty20 International ...

BridgeBio Oncology Therapeutics (BBOT) targets KRAS and PI3Ka malignancies with next-generation small molecule therapeutics, ...

The loss of domvanalimab is the latest in a string of high-profile failures recorded across the biopharma world for the TIGIT ...

They could grow into their valuation over the next few years.

GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...

Researchers led by investigators at Mass General Brigham have published valuable information about a rare but serious complication of anti-cancer immunotherapy, providing the first large-scale ...

Preoperative radiation improved T-cell infiltration among patients with hormone receptor-positive, HER2-negative breast ...

Merck Animal Health announced that the Food and Drug Administration granted conditional approval for EXOLT CATTLE-CA 1. It’s a new topical that’s approved for the prevention and treatment of ...